We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$4.22B
AUM Growth
-$693M
Cap. Flow
-$61M
Cap. Flow %
-1.45%
Top 10 Hldgs %
84.43%
Holding
46
New
10
Increased
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$350M
2
IVVD icon
Invivyd
IVVD
+$211M
3
BHIL
Benson Hill, Inc.
BHIL
+$146M
4
DUOL icon
Duolingo
DUOL
+$108M
5
ILMN icon
Illumina
ILMN
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 54.75%
2 Technology 32.88%
3 Financials 7.69%
4 Consumer Staples 2.5%
5 Industrials 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATH icon
1
UiPath
PATH
$5.62B
$925M 21.94%
17,581,428
-11,444,357
-39% -$693M
VERV
2
DELISTED
Verve Therapeutics
VERV
$516M 12.24%
10,974,011
DXCM icon
3
DexCom
DXCM
$27.6B
$440M 10.45%
3,222,724
OSCR icon
4
Oscar Health
OSCR
$8.5B
$418M 9.92%
24,042,864
LYFT icon
5
Lyft
LYFT
$5.39B
$329M 7.8%
6,138,154
HOOD icon
6
Robinhood
HOOD
$85.2B
$324M 7.68%
+7,697,335
New +$350M
IVVD icon
7
Invivyd
IVVD
$180M
$240M 5.69%
+5,680,785
New +$211M
RCUS icon
8
Arcus Biosciences
RCUS
$3.57B
$143M 3.39%
4,100,475
-513,343
-11% -$16M
DUOL icon
9
Duolingo
DUOL
$5.7B
$118M 2.81%
+712,304
New +$108M
BHIL
10
DELISTED
Benson Hill, Inc.
BHIL
$105M 2.5%
+421,493
New +$146M
LYEL icon
11
Lyell Immunopharma
LYEL
$309M
$86.8M 2.06%
293,256
DM
12
DELISTED
Desktop Metal, Inc.
DM
$79.2M 1.88%
1,104,873
SANA icon
13
Sana Biotechnology
SANA
$885M
$63.3M 1.5%
2,812,500
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$51.8M 1.23%
1,641,497
-185,379
-10% -$6.24M
GLUE icon
15
Monte Rosa Therapeutics
GLUE
$1.92B
$32.6M 0.77%
1,464,015
KRON
16
DELISTED
Kronos Bio
KRON
$30.1M 0.72%
1,438,232
BEAM icon
17
Beam Therapeutics
BEAM
$2.58B
$28M 0.66%
321,604
-313,982
-49% -$31.5M
BRNS
18
Barinthus Biotherapeutics
BRNS
$24.6M
$26.8M 0.64%
1,704,444
DNTH icon
19
Dianthus Therapeutics
DNTH
$5.68B
$24.3M 0.58%
208,696
RAPT
20
DELISTED
RAPT Therapeutics
RAPT
$22.1M 0.52%
88,781
-9,821
-10% -$2.6M
ILMN icon
21
Illumina
ILMN
$29.4B
$21.7M 0.51%
+54,967
New +$25.3M
IDYA icon
22
IDEAYA Biosciences
IDYA
$3.41B
$19.2M 0.46%
753,187
TNYA icon
23
Tenaya Therapeutics
TNYA
$168M
$18.9M 0.45%
+915,705
New +$19.7M
QNCX icon
24
Quince Therapeutics
QNCX
$17.5M
$17.3M 0.41%
946
VERA icon
25
Vera Therapeutics
VERA
$2.54B
$16.4M 0.39%
944,791

Similar funds

Alphabet Inc's Q3 2021 Portfolio in Review

As of Q3 2021, Alphabet Inc held 46 positions worth $4.22B, down 14% from $4.91B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Alphabet Inc's Q3 2021 filing shows 10 new, 6 reduced and 3 closed positions. Its largest new stake was Robinhood: 7,697,335 shares worth $324M. The largest sale was UiPath, an estimated $693M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 47% a quarter earlier, followed by Technology and Financials.

  • Alphabet Inc's largest Q3 2021 buy was Robinhood: 7,697,335 shares worth $324M.
  • Alphabet Inc's biggest Q3 2021 reduction was UiPath, cutting an estimated $693M.
  • Alphabet Inc fully exited Airbnb in Q3 2021, selling an estimated $80.5M.
  • Alphabet Inc's ten largest holdings make up 84% of its $4.22B portfolio in Q3 2021.
  • Alphabet Inc opened 10 new positions and closed 3 in Q3 2021.
  • Alphabet Inc's portfolio value fell 14% quarter-over-quarter to $4.22B.

Based on Alphabet Inc's 13F filing for Q3 2021, filed 15 Nov 2022.